In addition, thrombocytopenia can occur in patients with COVID-19 for various other reasons such as decreased thrombopoietin (TPO) production as a result of parenchymal liver injury, immune thrombocytopenic purpura (ITP), heparin-induced thrombocytopenia (HIT), hemophagocytic syndrome, and drug-induced myelosuppression (30, 33, 34). This evidence concerns the gene THPO and autoimmune thrombocytopenic purpura.